LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2024-0101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Jillian Cornish und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Lactoferrin, Anti-Bacterial Agents, Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Lactoferrin (Lf), we have previously shown, has therapeutic potential in the field of skeletal regenerative medicine demonstrating its potent stimulating effects on bone growth. Recently, we have identified bovine lactoferrin (bLf) as a factor that also enhances antibiotic killing of Staphylococcus aureus (S. aureus). Biofilms are associated with around 65% of all infections and 80% of chronic infections. One feature of biofilm infection is tolerance to antibiotics due to the survival of a subpopulation of biofilm bacteria, where laboratory tests on planktonic cells indicate susceptibility. Tolerance is seen in bone infections of osteomyelitis and prosthetic joints, where methicillin-susceptible S. aureus (MSSA) strains predominate, but where treatments with the frontline penicillinase-resistant antibiotic cefazolin (CEF) can be ineffective. In vitro-grown biofilms of MSSA are 1000-fold more tolerant to CEF but can be eradicated by CEF at 10x minimal inhibitory concentration in the presence of bLf. Bone infection can impede blood circulation within the bone, leading to bone death. Lf as a potent stimulator of bone growth adds to its appeal as a treatment for bone infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Auckland, Auckland, New Zealand.
- Red Rock Bioprocess Consulting, Denver, CO, USA.
- Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
- School of Pharmacy, University of Auckland, Auckland, New Zealand.
- Department of Surgery, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Jillian Cornish, Reece Joseph
Zitieren
APA
Cornish, J., Joseph, R., Lin, J., Irwin, S., Perera, J., Callon, K., Hassan, J., Wen, J., Crawford, H., Matthews, B., Ashton, N., Williams, D., Baker, H., Baker, E., & Swift, S. (2025). LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0101
Vancouver
Cornish J, Joseph R, Lin J, Irwin S, Perera J, Callon K, et al. LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0101
BibTeX
@article{Cornish2025,
author = {Cornish, Jillian and Joseph, Reece and Lin, Jian-Ming and Irwin, Stuart G and Perera, Janesha and Callon, Karen E and Hassan, Jagir R and Wen, Jingyuan and Crawford, Haemish and Matthews, Brya G and Ashton, Nicholas N and Williams, D and Baker, Heather M and Baker, Eduard N and Swift, Simon},
title = {LACTOFERRIN ENHANCES THE ANTIBIOTIC TREATMENT OF STAPHYLOCOCCUS AUREUS IN BONE INFECTION},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2024-0101}
}
EUVIMED